nsv4684016
- Organism: Homo sapiens
- Study:nstd191 (Dai et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh38 (hg38)
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:55,073,556
- Publication(s):Dai et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 72722 SVs from 109 studies. See in: genome view
Overlapping variant regions from other studies: 72506 SVs from 109 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4684016 | Submitted genomic | GRCh38 (hg38) | Primary Assembly | NC_000023.11 | ChrX | 32,915,769 | 87,989,324 | ||
| nsv4684016 | Remapped | Good | GRCh37.p13 | Primary Assembly | First Pass | NC_000023.10 | ChrX | 32,933,886 | 87,244,324 |
Variant Call Information
| Variant Call ID | Type | Sample ID | Method | Analysis |
|---|---|---|---|---|
| nssv16214889 | inversion | DMD001 | Sequencing | Sequence alignment |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16214889 | Submitted genomic | NC_000023.11:g.329 15769_87989324inv | GRCh38 (hg38) | NC_000023.11 | ChrX | 32,915,769 | 87,989,324 | ||
| nssv16214889 | Remapped | Good | NC_000023.10:g.329 33886_87244324inv | GRCh37.p13 | First Pass | NC_000023.10 | ChrX | 32,933,886 | 87,244,324 |